spacer
home > epc > summer 2019 > overcoming the industry data crisis
PUBLICATIONS
European Pharmaceutical Contractor

Overcoming the Industry Data Crisis




The amount of data generated around the world is growing exponentially and at rates that are so great they are difficult to grasp. By one calculation, 90% of the world’s data have been generated over the last two years (1). To put it in terms used by the International Data Corporation in its estimates: by 2025, the global datasphere will reach 175 zettabytes − the equivalent of 175 trillion gigabytes (2).

With data from the newest technologies, applications, devices, and wearables all contributing, the sheer breadth of available information in clinical research is staggering, and its potential for contributing positively to modernisation is virtually limitless. The pharmaceutical industry has progressively accepted electronic data capture (EDC) as the standard practice for clinical trials. Overall, the adoption of EDC has resulted in some improvement across the industry − relative to antiquated paper processes − but EDC still largely relies on paper-based source documents (3).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author

 
Ed Seguine, CEO at Clinical Ink, is passionate about creating solutions for problems caused by current clinical trial processes and technologies. With more than 20 years of experience as a clinical technology executive at Big Pharma and startup organisations, Ed, a thought leader on key initiatives including CDISC and eClinical Forum, often presents at industry events and publishes regularly on the benefits of next-generation eSource solutions. He earned a Master of Business Administration from Indiana University, Bloomington, US, and a Bachelor of Science in Finance from Brigham Young University, US.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Unveils its full Conference Line-up for SCOPE 2020

PHILADELPHIA, PA – February 11, 2020: The SCOPE Summit for Clinical Operations Executives annually convenes innovative thought leaders from across the life sciences industry to share ideas, challenges and best practices that will help drive change and improve patient centricity throughout the coming year and beyond. Subject matter experts from Signant Health will host and participate in key discussions on the importance of eConsent and patient engagement, the impact of data analytics on endpoint quality, and how to integrate sensors and wearables into eCOA trials as part of the patient journey through clinical research.
More info >>

White Papers

Choosing the Right CMO for HPAPI Manufacturing

AMRI

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement